Share

January 24, 2023; 100 (4) Editorial

The Role of Diet in Multiple Sclerosis

Food for Thought

Rebecca I. Spain, Laura Piccio, Annette M. Langer-Gould
First published October 18, 2022, DOI: https://doi.org/10.1212/WNL.0000000000201565
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
235

Share

Article Information

vol. 100 no. 4 167-168
DOI: 
https://doi.org/10.1212/WNL.0000000000201565
PubMed: 
36257715
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 4, 2022
  • Accepted in final form September 28, 2022
  • First Published October 18, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Rebecca I. Spain, MD, MSPH*,
    2. Laura Piccio, MD, PhD* and
    3. Annette M. Langer-Gould, MD, PhD*
  1. Rebecca I. Spain, MD, MSPH*,
    2. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. GLG, Inc. National Vaccine Injury Program

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Department of Veterans Affairs, (I01 RX002682-01), PI 2018- 2922

    Research Support, Academic Entities:

    1. 1. VA Portland Health Care System 2. Oregon Health & Science University

    Research Support, Foundations and Societies:

    1. National Multiple Sclerosis Society Multiple Sclerosis Society of Canada

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Laura Piccio, MD, PhD* and
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. Journal of Neuroimmunology Scientific Report

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. R01 NS102633-01 07/01/2018-06/30/2023 NIH Roles: (PIs: Laura Piccio and Yanjiao Zhou) $1,250,000 R01AG058501-01 Roles: (PIs: Cruchaga; Piccio) 04/01/2018-02/31/2023 NIH/NIA $3,718,710

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Multiple Sclerosis Society RG-1607-25158 04/01/2017-03/31/2021 Roles: (PI: Laura Piccio) $785,453 Total Costs

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Annette M. Langer-Gould, MD, PhD*
    4. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. My husband, Michael Gould, serves as the Deputy Editor for Annals of the American Thoracic Society for the past 5 years

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. I am a voting panel member of California Technology Assessment Forum, a core program of the Institute for Clinical and Economic Review (ICER) and have served as expert evaluator for ICER's evaluation of MS DMTs. ICER has paid for my travel for the round table meetings prior to 2020.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I currently receive grant support from PCORI (multiple PIs Piehl and Langer-Gould) and My husband currently receives grant support from the NIH, PCORI and NCI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Neurology Service (R.I.S.), VA Portland Health Care System, OR; Department of Neurology (R.I.S.), Oregon Health and Science University, Portland; Department of Pathology and Immunology (L.P.), Washington University in St. Louis, MO; Brain and Mind Centre (L.P.), School of Medical Sciences, University of Sydney, NSW, Australia; and Neurology Department (A.M.L.-G.), Southern California Permanente Medical Group/Kaiser Permanente, Los Angeles Medical Center, CA.
  1. Correspondence
    Dr. Spain spainr{at}ohsu.edu
View Full Text

Article usage

Article usage: October 2022 to May 2023

AbstractFullPdfSource
Oct 20220090Highwire
Nov 20220013Highwire
Dec 2022007Highwire
Jan 202397413760Highwire
Feb 20233773834Highwire
Mar 20233571715Highwire
Apr 20231961412Highwire
May 202318974Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me